TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | -100.0% | 137 | -77.7% | 0.00% | – |
Q3 2022 | $2,000 | -33.3% | 614 | +22.8% | 0.00% | – |
Q2 2022 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $3,000 | -25.0% | 500 | -3.1% | 0.00% | – |
Q4 2021 | $4,000 | 0.0% | 516 | +3.2% | 0.00% | – |
Q3 2021 | $4,000 | -93.9% | 500 | -89.7% | 0.00% | – |
Q1 2021 | $66,000 | -7.0% | 4,855 | -1.2% | 0.00% | – |
Q4 2020 | $71,000 | -21.1% | 4,915 | +1.2% | 0.00% | – |
Q3 2020 | $90,000 | +373.7% | 4,855 | -2.9% | 0.00% | – |
Q1 2020 | $19,000 | +72.7% | 5,000 | +150.0% | 0.00% | – |
Q4 2019 | $11,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corriente Advisors, LLC | 1,058,823 | $19,556,000 | 9.92% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $4,076,000 | 4.24% |
Mesirow Financial Investment Management, Inc. | 34,902 | $645,000 | 2.76% |
Gagnon Advisors, LLC | 176,471 | $3,259,000 | 2.00% |
Nantahala Capital Management | 2,032,988 | $37,549,000 | 1.15% |
PRECEPT MANAGEMENT LLC | 235,294 | $4,346,000 | 1.07% |
GAGNON SECURITIES LLC | 219,584 | $4,056,000 | 0.86% |
Sepio Capital, LP | 84,560 | $1,562,000 | 0.17% |
683 Capital Management, LLC | 117,647 | $2,173,000 | 0.16% |
SANDERS MORRIS HARRIS LLC | 21,326 | $340,000 | 0.09% |